Biocartis, bioMerieux Enter Into Strategic Agreement
bioMerieux and Biocartis have entered into a strategic agreement to codevelop assays, which the two companies will codistribute starting in 2012.
Read MorebioMerieux and Biocartis have entered into a strategic agreement to codevelop assays, which the two companies will codistribute starting in 2012.
Read MoreInternational Technidyne Corporation has completed its sale to affiliates of Warburg Pincus LLC, in an all-cash transaction valued at $55 million.
Read MoreThis month’s issue will be the last of 2010, as December will bring our annual CLP Buyer’s Guide your way. I’d like to take the opportunity to wish all of you—our readers and advertisers—happy and healthy holidays, since by t
Read MoreTwo oral presentations and five poster presentations during CHEST 2010 will collectively highlight the clinical and economic benefits of Oncimmune’s EarlyCDT-Lung.
Read MoreMolecular Detection Inc has been awarded a $244,500 federal Therapeutic Discovery Project grant.
Read More